Display Settings:

Format

Send to:

Choose Destination
Methods Enzymol. 2008;445:53-82. doi: 10.1016/S0076-6879(08)03003-6.

Chapter 3. Bone marrow-derived vascular progenitors and proangiogenic monocytes in tumors.

Author information

  • 1Department of Neurological Surgery, Brain Tumor Research Center, University of California-San Francisco, San Francisco, California, USA.

Abstract

In tumors, new blood vessels develop not only from pre-existing vessels (angiogenesis), but can also be comprised of circulating vascular progenitor cells originating from the bone marrow (vasculogenesis). Besides endothelial progenitor cells (EPC) and pericyte progenitor cells (PPCs) that are incorporated into the growing vasculature, other subpopulations of bone marrow-derived cells (BMDC) contribute indirectly to tumor neovascularization by providing growth factors, cytokines, and other key proangiogenic molecules. Here, we describe specific methods that allow for the identification and functional characterization of these distinct BMDC populations in tumors as exemplified in mouse models of pancreatic neuroendocrine tumors and glioblastomas.

PMID:
19022055
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk